[E-019] Safety and effectiveness of nusinersen in SMA type 2 and 3:Assessment of the real world data
Yuko Motohashi1, Hiroyuki Yajima2, Akihiko Ishiyama1, Eri Takeshita1, Yoko Kobayashi2, Hirofumi Komaki1, Masayuki Sasaki1 (1.National Center of Neurology and Psychiatry, Department of Child Neurology, Tokyo, Japan, 2.National Center of Neurology and Psychiatry, Department of Rehabilitation, Tokyo, Japan)